Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment

被引：15
|
作者：
Yang, Fei-Fei [1 ,2 ,3 ,4 ]
Hu, Ting [1 ,2 ,3 ,4 ]
Liu, Jian-Quan [1 ,2 ,3 ,4 ]
Yu, Xiao-Qian [1 ,2 ,3 ,4 ]
Ma, Li-Ying [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450001, Henan, Peoples R China
[2] Zhengzhou Univ, Minist Educ China, Key Lab Adv Pharmaceut Technol, Zhengzhou 450001, Henan, Peoples R China
[3] Zhengzhou Univ, Inst Pharmaceut Sci, Zhengzhou 450001, Henan, Peoples R China
[4] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Henan, Peoples R China
[5] China Meheco Topfond Pharmaceut Co, Key Lab Cardio Cerebrovasc Drug, Zhumadian 463000, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 245卷
基金：
中国博士后科学基金;
关键词：
Hematologic cancer; HDACs; Immunotherapy; NKG2D LIGAND EXPRESSION; B-CELL LYMPHOMA; ACUTE MYELOID-LEUKEMIA; NON-HODGKIN-LYMPHOMA; REGULATORY T-CELLS; MULTIPLE-MYELOMA; ANTITUMOR IMMUNITY; VALPROIC ACID; TUMOR-CELLS; IN-VIVO;
D O I：
10.1016/j.ejmech.2022.114920
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Bone marrow transplantation is regarded as the most effective immunotherapy for hematologic cancer, but it generally faces difficulties in matching. Aberrant expression of histone deacetylases (HDACs) is closely related to the occurrence and development of hematological cancer. Recent studies suggested that HDACs might play a critical role in initiating anti-cancer immune response or enhancing anti-cancer immunotherapy. Besides, combining HDAC inhibition and immunotherapy could prevent immunotherapy resistance in some degree and reach an extended treatment window. This review summarized the relationship between HDACs and immune and described the current understanding of HDACs in immunotherapy for hematologic cancer.
引用
收藏
页数：13
相关论文
共 50 条
  • [1] Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors
    Palamaris, Kostas
    Tzimou, Luisa-Maria
    Levidou, Georgia
    Masaoutis, Christos
    Theochari, Irene
    Rontogianni, Dimitra
    Theocharis, Stamatios
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [2] The role of histone deacetylases (HDACs) in human cancer
    Ropero, Santiago
    Esteller, Manel
    MOLECULAR ONCOLOGY, 2007, 1 (01) : 19 - 25
  • [3] Histone Deacetylases (HDACs) Are Potential Biochemical Targets for Insecticide Development
    Yang, Jing-Fang
    Shi, Le-Rong
    Zhang, Zhong-Kai
    Zhou, Zhong-Shi
    Wan, Fang-Hao
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2024, 72 (02) : 953 - 955
  • [4] Histone deacetylases as therapeutic targets in hematologic malignancies
    Melnick, A
    Licht, JD
    CURRENT OPINION IN HEMATOLOGY, 2002, 9 (04) : 322 - 332
  • [5] Histone deacetylases (HDACs) and senescence
    Warnon, C.
    Bouhjar, K.
    Verhoyen, M.
    Mottet, D.
    Geraldine, P.
    Debacq-Chainiaux, F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S276 - S276
  • [6] Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer
    Xu, Xiaoxin S.
    Wang, Le
    Abrams, Judith
    Wang, Gan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2011, 4
  • [7] Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer
    Xiaoxin S Xu
    Le Wang
    Judith Abrams
    Gan Wang
    Journal of Hematology & Oncology, 4
  • [8] Histone deacetylases as promising drug targets for treatment of esophageal squamous cell carcinoma
    Morishima, Kazue
    Saito, Shin
    Matsubara, Daisuke
    Hosoya, Yoshinori
    Sata, Naohiro
    Yasuda, Yoshikazu
    Ishikawa, Shumpei
    Niki, Toshiro
    CANCER RESEARCH, 2012, 72
  • [9] The contributory roles of histone deacetylases (HDACs) in hematopoiesis regulation and possibilities for pharmacologic interventions in hematologic malignancies
    Mehrpouri, Mahdieh
    Pourbagheri-Sigaroodi, Atieh
    Bashash, Davood
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 100
  • [10] Histone deacetylases (HDACs) in frontotemporal lobar degeneration
    Whitehouse, A.
    Doherty, K.
    Yeh, H. H.
    Robinson, A. C.
    Rollinson, S.
    Pickering-Brown, S.
    Snowden, J.
    Thompson, J. C.
    Davidson, Y. S.
    Mann, D. M. A.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 (02) : 245 - 257
12345